Headquartered on the University of Delaware’s STAR Campus, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a consortium of industry, academic institutions, government agencies, and non-profit organizations working in collaboration to advance biopharmaceutical manufacturing innovation and workforce development in the United States.
$15.2M awarded to projects that include a Delaware organization.
Delaware organizations have participated on a total of 24 NIIMBL-funded projects.
$4.9M awarded directly to projects led by a Delaware organization.
NIIMBL has subsidized almost $735K in membership fees for Delaware-based academic institutions and small- to medium-sized businesses.
Delaware organizations participated in 24 NIIMBL-funded projects.
Delaware organizations represent 12% of NIIMBL’s national membership.
58% are small- to medium-sized organizations with 500 employees or less.
NIIMBL programs have introduced 100 students in Delaware to secure, well-paying, and high-need career pathways in the biopharmaceutical manufacturing industry.
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.
